EXOSENS SAS (EXENS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EXENS - FR001400Q9V2 - Common Stock
48.45 EUR
-0.05 (-0.1%)
EXENS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 45 industry peers in the Aerospace & Defense industry. While EXENS has a great health rating, its profitability is only average at the moment. EXENS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
EXENS had positive earnings in the past year.
In the past year EXENS had a positive cash flow from operations.
1.2 Ratios
With a Return On Assets value of 3.54%, EXENS perfoms like the industry average, outperforming 48.89% of the companies in the same industry.
With a Return On Equity value of 7.14%, EXENS is not doing good in the industry: 62.22% of the companies in the same industry are doing better.
EXENS has a Return On Invested Capital (7.97%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for EXENS is below the industry average of 9.26%.
The 3 year average ROIC (7.01%) for EXENS is below the current ROIC(7.97%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 7.14% | ||
| ROIC | 7.97% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
1.3 Margins
EXENS has a better Profit Margin (7.79%) than 73.33% of its industry peers.
With an excellent Operating Margin value of 18.28%, EXENS belongs to the best of the industry, outperforming 95.56% of the companies in the same industry.
The Gross Margin of EXENS (73.86%) is better than 95.56% of its industry peers.
In the last couple of years the Gross Margin of EXENS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
2. Health
2.1 Basic Checks
EXENS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EXENS has less shares outstanding than it did 1 year ago.
EXENS has a better debt/assets ratio than last year.
2.2 Solvency
EXENS has an Altman-Z score of 4.48. This indicates that EXENS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of EXENS (4.48) is better than 82.22% of its industry peers.
EXENS has a debt to FCF ratio of 4.69. This is a neutral value as EXENS would need 4.69 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.69, EXENS is doing good in the industry, outperforming 64.44% of the companies in the same industry.
EXENS has a Debt/Equity ratio of 0.61. This is a neutral value indicating EXENS is somewhat dependend on debt financing.
EXENS has a Debt to Equity ratio of 0.61. This is in the lower half of the industry: EXENS underperforms 64.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.69 | ||
| Altman-Z | 4.48 |
ROIC/WACC0.94
WACC8.47%
2.3 Liquidity
EXENS has a Current Ratio of 2.51. This indicates that EXENS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.51, EXENS belongs to the best of the industry, outperforming 91.11% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that EXENS should not have too much problems paying its short term obligations.
The Quick ratio of EXENS (1.67) is better than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 102.95% over the past year.
Looking at the last year, EXENS shows a very strong growth in Revenue. The Revenue has grown by 35.04%.
EXENS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.36% yearly.
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%875.18%
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%20.13%
3.2 Future
EXENS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.39% yearly.
The Revenue is expected to grow by 13.35% on average over the next years. This is quite good.
EPS Next Y52.91%
EPS Next 2Y37.35%
EPS Next 3Y30.24%
EPS Next 5Y25.39%
Revenue Next Year17.96%
Revenue Next 2Y16.32%
Revenue Next 3Y14.79%
Revenue Next 5Y13.35%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 65.47 indicates a quite expensive valuation of EXENS.
Based on the Price/Earnings ratio, EXENS is valued a bit more expensive than the industry average as 64.44% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.51. EXENS is valued rather expensively when compared to this.
EXENS is valuated quite expensively with a Price/Forward Earnings ratio of 25.93.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXENS is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, EXENS is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.47 | ||
| Fwd PE | 25.93 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXENS.
The rest of the industry has a similar Price/Free Cash Flow ratio as EXENS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 43.23 | ||
| EV/EBITDA | 23.26 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EXENS's earnings are expected to grow with 30.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.24
PEG (5Y)N/A
EPS Next 2Y37.35%
EPS Next 3Y30.24%
5. Dividend
5.1 Amount
EXENS has a yearly dividend return of 0.22%, which is pretty low.
EXENS's Dividend Yield is slightly below the industry average, which is at 0.90.
Compared to an average S&P500 Dividend Yield of 2.00, EXENS's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y37.35%
EPS Next 3Y30.24%
EPA:EXENS (12/31/2025, 7:00:00 PM)
48.45
-0.05 (-0.1%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners47.07%
Inst Owner ChangeN/A
Ins Owners1.86%
Ins Owner ChangeN/A
Market Cap2.47B
Revenue(TTM)394.08M
Net Income(TTM)30.68M
Analysts76.67
Price Target50.91 (5.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.98%
PT rev (3m)17.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.67%
EPS NY rev (3m)-3.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.09%
Revenue NY rev (3m)-1.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.47 | ||
| Fwd PE | 25.93 | ||
| P/S | 6.26 | ||
| P/FCF | 43.23 | ||
| P/OCF | 24.41 | ||
| P/B | 5.75 | ||
| P/tB | N/A | ||
| EV/EBITDA | 23.26 |
EPS(TTM)0.74
EY1.53%
EPS(NY)1.87
Fwd EY3.86%
FCF(TTM)1.12
FCFY2.31%
OCF(TTM)1.98
OCFY4.1%
SpS7.74
BVpS8.43
TBVpS-0.02
PEG (NY)1.24
PEG (5Y)N/A
Graham Number11.85
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 7.14% | ||
| ROCE | 9.7% | ||
| ROIC | 7.97% | ||
| ROICexc | 9.07% | ||
| ROICexgc | 26.62% | ||
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% | ||
| FCFM | 14.49% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
ROICexc(3y)7.64%
ROICexc(5y)N/A
ROICexgc(3y)25.3%
ROICexgc(5y)N/A
ROCE(3y)8.53%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.69 | ||
| Debt/EBITDA | 2.32 | ||
| Cap/Depr | 105.56% | ||
| Cap/Sales | 11.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 88.9% | ||
| Profit Quality | 186.1% | ||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.48 |
F-Score6
WACC8.47%
ROIC/WACC0.94
Cap/Depr(3y)105.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.64%
Cap/Sales(5y)N/A
Profit Quality(3y)171.48%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%875.18%
EPS Next Y52.91%
EPS Next 2Y37.35%
EPS Next 3Y30.24%
EPS Next 5Y25.39%
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%20.13%
Revenue Next Year17.96%
Revenue Next 2Y16.32%
Revenue Next 3Y14.79%
Revenue Next 5Y13.35%
EBIT growth 1Y45.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.83%
EBIT Next 3Y32.9%
EBIT Next 5Y25.17%
FCF growth 1Y181.68%
FCF growth 3Y33.59%
FCF growth 5YN/A
OCF growth 1Y90.75%
OCF growth 3Y31.16%
OCF growth 5YN/A
EXOSENS SAS / EXENS.PA FAQ
What is the fundamental rating for EXENS stock?
ChartMill assigns a fundamental rating of 5 / 10 to EXENS.PA.
What is the valuation status for EXENS stock?
ChartMill assigns a valuation rating of 2 / 10 to EXOSENS SAS (EXENS.PA). This can be considered as Overvalued.
Can you provide the profitability details for EXOSENS SAS?
EXOSENS SAS (EXENS.PA) has a profitability rating of 4 / 10.
How financially healthy is EXOSENS SAS?
The financial health rating of EXOSENS SAS (EXENS.PA) is 6 / 10.
What is the expected EPS growth for EXOSENS SAS (EXENS.PA) stock?
The Earnings per Share (EPS) of EXOSENS SAS (EXENS.PA) is expected to grow by 52.91% in the next year.